Bone And Joint Health Ingredients Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Bone and Joint Health Ingredients Market Report Segments the Industry Into by Type (Vitamin, Calcium, Collagen, Magnesium, and More), by Source (Plant-Derived, Animal-Derived, and Others), by Form (Powder, Liquid, and Others), by Application (Dietary Supplement, Functional Food and Beverage, and Others) and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Bone And Joint Health Ingredients Market Size and Share

Bone And Joint Health Ingredients Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Bone And Joint Health Ingredients Market with other markets in Food & Beverage Industry

Bone And Joint Health Ingredients Market Analysis by Mordor Intelligence

Market Overview

The bone joint health ingredients market is valued at USD 4.22 billion in 2025 and is projected to reach USD 5.87 billion by 2030, registering a CAGR of 6.82% during the forecast period. This growth trajectory reflects the convergence of demographic shifts, regulatory evolution, and technological innovation that positions joint health ingredients as critical components in preventive healthcare strategies. The market's expansion is fundamentally driven by the rising prevalence of osteoarthritis and osteoporosis, with scientific claims indicating that higher omega-3 intake reduces osteoporosis risk by ~30% among consumers. Regulatory frameworks across key markets are creating unprecedented opportunities for market expansion, particularly in Asia-Pacific, where China's State Administration of Market Regulation is drafting regulations to allow health foods to make joint health support claims, including benefits for alleviating joint pain and maintaining joint cartilage health.

Key Report Takeaways

  • By type, the vitamin category held 32.15% of the bone and joint health ingredients market share in 2024; calcium is forecast to expand at an 8.65% CAGR to 2030.
  • By source, animal-derived ingredients captured 55.66% of the bone and joint health ingredients market share in 2024, while plant-derived alternatives are projected to grow at a 10.61% CAGR through 2030.
  • By form, powder formulations commanded 63.13% of the bone and joint health ingredients market size in 2024 and are advancing at an 8.91% CAGR during 2025-2030.
  • By application, dietary supplements accounted for 53.15% of the bone and joint health ingredients market size in 2024 and are set to record the fastest CAGR at 9.15% to 2030.
  • By geography, North America led with 35.15% revenue share in 2024, whereas Asia-Pacific is the fastest expanding region at an 8.96% CAGR through the forecast period.

Segment Analysis

By Type: Calcium Drives Innovation Despite Vitamin Dominance

The vitamin group anchored 32.15% of the bone and joint health ingredients market share in 2024, underpinned by broad clinical validation for vitamins D3, K2, and C in mineralization and collagen synthesis. Emerging formulation advances keep this portfolio relevant, yet calcium is racing ahead with an 8.65% CAGR on the back of chelation technologies and prebiotic co-administration systems that raise fractional absorption. Collagen maintains steady growth through marine-derived alternatives that offer superior bioavailability compared to mammalian sources, while glucosamine benefits from regulatory recognition in markets like China, where health products containing glucosamine have received approval for increasing bone density. 

Magnesium demonstrates consistent performance through its established role in bone mineral density regulation and osteoblast/osteoclast activity modulation. Omega-3 segments are experiencing renewed interest following research demonstrating a 32% reduction in osteoporosis odds among the highest intake quartiles, driving innovation in specialized delivery systems that address oxidation challenges and improve bioavailability. Hyaluronic acid represents an emerging growth segment, supported by clinical evidence of its effectiveness in alleviating ovariectomy-induced bone loss through osteoblast proliferation promotion and osteoclast activity inhibition.

Bone And Joint Health Ingredients Market: Market Share by Type
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Source: Plant-Derived Alternatives Challenge Animal Dominance

Plant-derived sources are rapidly gaining market traction at 10.61% CAGR through 2030, despite animal-derived ingredients maintaining 55.66% market share in 2024. This shift reflects consumer preferences for sustainable, allergen-free alternatives and regulatory support for plant-based innovations. Traditional Chinese medicine flavonoids are emerging as significant contributors to plant-derived growth, offering advantages including fewer side effects and cost-effectiveness for long-term use compared to conventional drugs.

Animal-derived sources maintain their dominance through established supply chains and proven efficacy profiles, particularly in collagen and chondroitin sulfate applications where molecular structure and bioactivity are well-characterized. The segment benefits from regulatory clarity, with established Generally Recognized as Safe (GRAS) notices for ingredients like hydrolyzed porcine trachea cartilage containing type II collagen and chondroitin sulfate. However, sustainability concerns and ethical considerations are driving innovation toward fermentation-based production methods that can replicate animal-derived compound structures while addressing supply chain vulnerabilities. Other sources, including synthetic and fermentation-derived alternatives, represent emerging opportunities for manufacturers seeking to balance efficacy, sustainability, and cost considerations in their product portfolios.

By Form: Powder Dominance Reflects Processing Innovation

Powders owned 63.13% of the bone and joint health ingredients market in 2024 and are still the fastest mover at an 8.91% CAGR. That paradox is made possible by process upgrades, spray-chilling, fluid-bed agglomeration, and lipid-layer microencapsulation that remove the gritty mouthfeel and fishy notes once associated with collagen or glucosamine. Commercial beverage lines now dispense shelf-stable, clear solutions that incorporate 10 g of protein per serving without cloudiness, a leap that migrates powder into ready-to-drink channels.

Liquid formulations maintain steady market presence through specialized applications in sports nutrition and clinical settings where rapid absorption and precise dosing are critical requirements. The segment benefits from innovations in emulsification technologies and stabilization systems that extend shelf life and improve palatability. Liquid forms particularly excel in pediatric and geriatric applications where swallowing difficulties make powder or solid alternatives less suitable. Other forms, including gummies, soft gels, and effervescent tablets, represent growing market segments driven by consumer convenience preferences and improved manufacturing technologies that maintain ingredient stability and bioactivity across diverse delivery mechanisms.

Bone And Joint Health Ingredients Market: Market Share by Form
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Application: Dietary Supplements Retain Primacy, Functional Foods Accelerate

Dietary supplements maintain market leadership with 53.15% share in 2024 and demonstrate continued growth momentum at 9.15% CAGR through 2030, reflecting the segment's adaptability to evolving consumer preferences and regulatory frameworks. This growth is supported by increasing sophistication in formulation science, including combination products that address multiple aspects of bone and joint health through synergistic ingredient interactions. The segment benefits from established regulatory pathways and consumer acceptance, particularly in markets like the United States, where dietary supplement regulations provide clear guidelines for product development and marketing claims.

The increasing demand for functional foods and beverages that deliver specific health benefits has driven growth in bone and joint health ingredients, especially among consumers looking to maintain mobility and wellness. Innovations such as calcium-fortified drinks paired with chicory-root prebiotic fiber have demonstrated greater calcium uptake in humans. Brands are equally exploring clear-protein Ready to Drink (RTD)'s enriched with type II collagen to serve wellness-minded millennials who prefer nutrition “in the meal.” Cosmetics and topical patches form a small but strikingly innovative sub-segment that exploits transdermal channels to reach peri-articular tissues, a direction underpinned by micro-needle array technology transferring hyaluronic acid deeper than conventional creams.

Geography Analysis

North America maintains its position as the dominant regional market with a 35.15% share in 2024, driven by established healthcare infrastructure, regulatory clarity, and high consumer awareness of preventive health strategies. The region benefits from well-developed distribution channels and premium pricing acceptance for scientifically validated products. Regulatory frameworks in the United States provide clear pathways for ingredient approval, with established Generally Recognized as Safe (GRAS) notice procedures that enable market entry for novel compounds like olive leaf extract containing at least 50% polyphenols and 40% oleuropein. The region's growth is supported by increasing integration of joint health ingredients into functional foods and beverages, with manufacturers leveraging advanced processing technologies to address taste and stability challenges. 

The Asia-Pacific market is expected to grow at a CAGR of 8.96% during 2025-2030, making it the fastest-growing region. This growth stems from increasing disposable incomes, urbanization, and health awareness, especially in China and India. The region's consumers are focusing more on preventive healthcare, increasing the demand for functional foods and supplements that support bone and joint health. Government programs supporting healthy aging and investments in food processing technologies enable manufacturers to develop products aligned with local preferences, supporting continued growth in the bone and joint health ingredients market.

Europe demonstrates steady market performance through stringent regulatory standards that ensure product quality and safety while creating barriers to entry for lower-quality alternatives. The European Food Safety Authority's rigorous health claim evaluation process, while challenging for manufacturers, ultimately supports premium market positioning for approved products. EFSA's scientific opinions on ingredients like collagen hydrolysate and glucosamine provide regulatory clarity that enables informed product development decisions[3]Source: European Food Safety Authority, “Scientific Opinion on Collagen Hydrolysate,” efsa.europa.eu. European manufacturers benefit from advanced processing technologies and established supply chains that enable efficient production and distribution across diverse national markets with varying regulatory requirements.

Bone And Joint Health Ingredients Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The bone and joint health ingredients market is moderately fragmented, with the top five companies holding a significant share of the global market, while regional specialists and new companies focusing on fermentation technology maintain a competitive presence. The industry structure enables diverse market participation, ranging from established multinational nutrition companies to specialized biotechnology firms that develop innovative ingredients. This competitive landscape enables continuous product development and technological advancement in ingredient manufacturing processes, particularly in areas such as bioavailability and sustainable production methods. 

Top incumbents, including DSM-Firmenich AG, BASF SE, Archer Daniels Midland Company, Glanbia plc, and Cargill Incorporated, among others, leverage ingredient breadth and regulatory infrastructure to secure multinational listings. DSM-Firmenich’s 2024 vitamin restructuring freed capital for yeast-fermented collagen trials, aiming to cut the cost of goods by 18% over traditional fish scaling. BASF applies lipid-matrix microencapsulation originally developed for carotenoids to joint-health actives, prolonging shelf life in tropical climates. 

Strategically, acquisitions focus on platform technologies rather than commodity volume. Glanbia’s 2024 buyout of a micro-encapsulation specialist expanded its optionality across dairy, bar, and beverage formats. Partnerships are likewise sharpened: Lonza’s capsule division co-develops sustained-release beadlets with Kappa Bioscience’s vitamin K2, seeking a one-pill bone formulation valid across North American, EU, and ASEAN regulatory categories.

Bone And Joint Health Ingredients Industry Leaders

  1. DSM-Firmenich AG

  2. BASF SE

  3. Archer-Daniels-Midland Company

  4. Glanbia plc

  5. Cargill, Incorporated

  6. *Disclaimer: Major Players sorted in no particular order
Bone and Joint Health Ingredients Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • February 2025: GC Rieber VivoMega introduced EPA and DHA Algae 1060 TG Premium, a concentrated algal omega-3 oil that delivers EPA and DHA in triglyceride form. The microalgae-sourced ingredient serves as a plant-based alternative to fish oil, meeting the increasing demand for vegan omega-3 options. The product supports nutraceutical applications for heart, brain, and joint health markets, featuring high purity standards, oxidative stability, and supply chain traceability.
  • June 2024: Glanbia Nutritionals launched a high-potency collagen tripeptide ingredient that provides enhanced bioavailability and targeted benefits for skin, joint, and bone health. The ingredient uses advanced hydrolysis techniques to create a specific tripeptide profile, which improves absorption compared to standard collagen peptides. The company intends to incorporate the ingredient into powders, ready-to-drink beverages, and functional foods, meeting consumer demand for convenient health products.
  • January 2024: DSM partnered with Azelis Pharmaceuticals and Healthcare to strengthen and expand Azelis Pharmaceuticals and Healthcare’s lateral value chain in India, with DSM’s complete range of vitamins for pharmaceutical solutions.
  • October 2023: DSM-Firmenich announced the launch of Life's™ Omega 03020, a concentrated algal omega-3 ingredient that provides EPA and DHA from a single source. The product addresses increasing consumer demand for plant-based alternatives to fish oil while supporting cardiovascular, brain, eye, and joint health. The ingredient offers manufacturers a solution with traceability, proven bioavailability, and environmental sustainability benefits.

Table of Contents for Bone And Joint Health Ingredients Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Osteoarthritis and Osteoporosis
    • 4.2.2 Growing consumer awareness of preventive joint health and self-medication
    • 4.2.3 Increasing demand from athletes and fitness professionals for joint-support products
    • 4.2.4 Rising obesity rates increasing joint stress and osteoarthritis risk
    • 4.2.5 Growing demand for personalized joint health solutions
    • 4.2.6 Increasing integration of joint health ingredients in functional foods and beverages
  • 4.3 Market Restraints
    • 4.3.1 Price volatility of key raw materials
    • 4.3.2 High manufacturing costs impacting product pricing and accessibility
    • 4.3.3 Competition from conventional pharmaceutical products
    • 4.3.4 Inconsistent regional regulations for health claims and product approvals.
  • 4.4 Supply Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Type
    • 5.1.1 Vitamin
    • 5.1.2 Calcium
    • 5.1.3 Collagen
    • 5.1.4 Magnesium
    • 5.1.5 Glucosamine
    • 5.1.6 Omega-3
    • 5.1.7 Hyaluronic Acid
    • 5.1.8 Others
  • 5.2 By Source
    • 5.2.1 Plant-derived
    • 5.2.2 Animal-derived
    • 5.2.3 Others
  • 5.3 By Form
    • 5.3.1 Powder
    • 5.3.2 Liquid
    • 5.3.3 Others
  • 5.4 By Application
    • 5.4.1 Dietary Supplements
    • 5.4.2 Functional Food and Beverage
    • 5.4.3 Others
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.1.4 Rest of North America
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 France
    • 5.5.2.3 United Kingdom
    • 5.5.2.4 Spain
    • 5.5.2.5 Netherlands
    • 5.5.2.6 Italy
    • 5.5.2.7 Sweden
    • 5.5.2.8 Poland
    • 5.5.2.9 Belgium
    • 5.5.2.10 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Indonesia
    • 5.5.3.7 Thailand
    • 5.5.3.8 Singapore
    • 5.5.3.9 Rest of Asia-Pacific
    • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Chile
    • 5.5.4.4 Colombia
    • 5.5.4.5 Peru
    • 5.5.4.6 Rest of South America
    • 5.5.5 Middle East and Africa
    • 5.5.5.1 United Arab Emirates
    • 5.5.5.2 South Africa
    • 5.5.5.3 Nigeria
    • 5.5.5.4 Saudi Arabia
    • 5.5.5.5 Egypt
    • 5.5.5.6 Morocco
    • 5.5.5.7 Turkey
    • 5.5.5.8 Rest of Middle East and Africa

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Ranking Analysis
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.4.1 DSM-Firmenich AG
    • 6.4.2 BASF SE
    • 6.4.3 Archer-Daniels-Midland Company
    • 6.4.4 Glanbia plc
    • 6.4.5 Cargill, Incorporated
    • 6.4.6 Darling Ingredients Inc.
    • 6.4.7 Gelita AG
    • 6.4.8 Lonza Group AG
    • 6.4.9 Kerry Group plc
    • 6.4.10 Kappa Bioscience
    • 6.4.11 Synutra Ingredients
    • 6.4.12 Balchem Corp.
    • 6.4.13 Givaudan SA
    • 6.4.14 Martin Bauer Group
    • 6.4.15 BioCell Technology, LLC
    • 6.4.16 Bioiberica S.A.U.
    • 6.4.17 Titan Biotech Ltd
    • 6.4.18 Collagen Life Sciences
    • 6.4.19 Symrise AG
    • 6.4.20 Chr. Hansen A/S

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Bone And Joint Health Ingredients Market Report Scope

The bone and joint health ingredients market provides a range of health-oriented ingredients dedicated to dietary supplements, functional food and beverage, and other industries, such as pharmaceuticals. The product offerings of the market revolve around major ingredients, including Vitamin D, Vitamin K, Calcium, Collagen, Magnesium, Glucosamine, Omega-3, and Other Types. By Application, the market is segmented into Dietary Supplements, Functional Foods and Beverages, and Other Applications. By geography, the study covers North America, Europe, Asia-Pacific, South America, and Middle-East and Africa. For each segment, the market sizing and forecasts have been done on the basis of the value (in USD million).

By Type Vitamin
Calcium
Collagen
Magnesium
Glucosamine
Omega-3
Hyaluronic Acid
Others
By Source Plant-derived
Animal-derived
Others
By Form Powder
Liquid
Others
By Application Dietary Supplements
Functional Food and Beverage
Others
Geography North America United States
Canada
Mexico
Rest of North America
Europe Germany
France
United Kingdom
Spain
Netherlands
Italy
Sweden
Poland
Belgium
Rest of Europe
Asia-Pacific China
India
Japan
Australia
South Korea
Indonesia
Thailand
Singapore
Rest of Asia-Pacific
South America Brazil
Argentina
Chile
Colombia
Peru
Rest of South America
Middle East and Africa United Arab Emirates
South Africa
Nigeria
Saudi Arabia
Egypt
Morocco
Turkey
Rest of Middle East and Africa
By Type
Vitamin
Calcium
Collagen
Magnesium
Glucosamine
Omega-3
Hyaluronic Acid
Others
By Source
Plant-derived
Animal-derived
Others
By Form
Powder
Liquid
Others
By Application
Dietary Supplements
Functional Food and Beverage
Others
Geography
North America United States
Canada
Mexico
Rest of North America
Europe Germany
France
United Kingdom
Spain
Netherlands
Italy
Sweden
Poland
Belgium
Rest of Europe
Asia-Pacific China
India
Japan
Australia
South Korea
Indonesia
Thailand
Singapore
Rest of Asia-Pacific
South America Brazil
Argentina
Chile
Colombia
Peru
Rest of South America
Middle East and Africa United Arab Emirates
South Africa
Nigeria
Saudi Arabia
Egypt
Morocco
Turkey
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current bone and joint health ingredients market size and how fast is it growing?

The market is valued at USD 4.22 billion in 2025 and is projected to reach USD 5.87 billion by 2030, expanding at a 6.82% CAGR.

Which ingredient category is growing the fastest?

Calcium-based innovations are rising at an 8.65% CAGR thanks to new bioavailability-enhancing technologies.

Why is Asia-Pacific the fastest-growing region?

Regulatory reforms in China and rising disposable incomes across emerging economies are fueling adoption, resulting in an 8.96% regional CAGR.

What form factor dominates sales today?

Powder formulations command 63.13% of 2024 revenue and still outpace other forms at an 8.91% CAGR due to processing advances that improve taste and solubility.

Page last updated on: July 10, 2025

Bone And Joint Health Ingredients Market Report Snapshots